Though India has built a robust domestic biosimilar market, its international presence and the ability to lower prices as compared to small molecule generics remain limited.
Weitere Episoden von „ThePrint“
Verpasse keine Episode von “ThePrint” und abonniere ihn in der kostenlosen GetPodcast App.